BCR-ABL-IN-2 is an inhibitor of BCR-ABL1 tyrosine kinase, with IC 50 s of 57 nM, 773 nm for ABL1 native and ABL1 T315I , respectively.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Bcr-Abl
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.